14 results
ARS
2024 FY
CCCC
C4 Therapeutics Inc
30 Apr 24
Annual report to shareholders
8:52am
in the event of a security incident. These types of mandatory disclosures are costly, could lead to negative publicity, and may cause our partners to lose
ARS
fwgb1rj gdxi7w2ohc
28 Apr 23
Annual report to shareholders
7:03am
S-3ASR
EX-1.2
j13qqonqh00
10 Nov 21
Automatic shelf registration
5:19pm
S-1
EX-3.4
zwsir52r
10 Sep 20
IPO registration
5:26pm
S-1
EX-10.14
ff8vps3vu02bm34jevl
10 Sep 20
IPO registration
5:26pm
DRS
EX-10.9
0ypbyt8
6 Aug 20
Draft registration statement
12:00am
DRS
EX-3.3
7ylkk9sl2sz egpxc2
6 Aug 20
Draft registration statement
12:00am
- Prev
- 1
- Next